 | • レポートコード：QAF27804 • 出版社/出版日：QYResearch / 2021年4月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の神経バイオマーカー市場について種類別（プロテオミクス、ゲノミクス、画像、バイオインフォマティクス、その他）、用途別（診断、創薬、個別化医療、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・神経バイオマーカー市場の概要 ・世界の主要地域別神経バイオマーカー市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の神経バイオマーカー市場規模2016-2021：種類別（プロテオミクス、ゲノミクス、画像、バイオインフォマティクス、その他） ・世界の神経バイオマーカー市場予測2012-2027：種類別（プロテオミクス、ゲノミクス、画像、バイオインフォマティクス、その他） ・世界の神経バイオマーカー市場規模2016-2021：用途別（診断、創薬、個別化医療、その他） ・世界の神経バイオマーカー市場予測2012-2027：用途別（診断、創薬、個別化医療、その他） ・神経バイオマーカーのアメリカ市場規模と予測2016-2021 ・神経バイオマーカーのヨーロッパ市場規模と予測2016-2021 ・神経バイオマーカーの中国市場規模と予測2016-2021 ・神経バイオマーカーの日本市場規模と予測2016-2021 ・神経バイオマーカーの東南アジア市場規模と予測2016-2021 ・神経バイオマーカーのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Thermo Fisher Scientific、Merck、Quest Diagnostics、Abbott、Roche、Illumina、Bio-Rad Laboratories、QIAGEN、Myriad RBM、Cisbio Bioassays、Athena Diagnostics、BGI、Wuxi APP、Aepodia、Proteome Sciences、Genewiz） ・神経バイオマーカーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・神経バイオマーカーの市場動向・機会・課題 ・調査の結論 |
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
The classification of Neurological Biomarkers includes Proteomics, Genomics, Imaging, Bioinformatics and others, and the proportion of Proteomics in 2017 is about 31%.
Market Analysis and Insights: Global Neurological Biomarkers Market
The global Neurological Biomarkers market was valued at US$ 6898.8 in 2020 and will reach US$ 11960 million by the end of 2027, growing at a CAGR of 9.6% during 2022-2027.
Global Neurological Biomarkers Scope and Market Size
The global Neurological Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurological Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Proteomics
Genomics
Imaging
Bioinformatics
Others
Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others
The Neurological Biomarkers market is analysed and market size information is provided by regions (countries). Segment by Application, the Neurological Biomarkers market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
1 Neurological Biomarkers Market Overview
1.1 Neurological Biomarkers Product Scope
1.2 Neurological Biomarkers Segment by Type
1.2.1 Global Neurological Biomarkers Sales by Type (2016 & 2021 & 2027)
1.2.2 Proteomics
1.2.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Neurological Biomarkers Segment by Application
1.3.1 Global Neurological Biomarkers Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Neurological Biomarkers Market Estimates and Forecasts (2016-2027)
1.4.1 Global Neurological Biomarkers Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Neurological Biomarkers Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Neurological Biomarkers Price Trends (2016-2027)
2 Neurological Biomarkers Estimates and Forecasts by Region
2.1 Global Neurological Biomarkers Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Neurological Biomarkers Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Neurological Biomarkers Sales Market Share by Region (2016-2021)
2.2.2 Global Neurological Biomarkers Revenue Market Share by Region (2016-2021)
2.3 Global Neurological Biomarkers Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Neurological Biomarkers Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Neurological Biomarkers Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Neurological Biomarkers Estimates and Projections (2016-2027)
2.4.2 Europe Neurological Biomarkers Estimates and Projections (2016-2027)
2.4.3 China Neurological Biomarkers Estimates and Projections (2016-2027)
2.4.4 Japan Neurological Biomarkers Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Neurological Biomarkers Estimates and Projections (2016-2027)
2.4.6 India Neurological Biomarkers Estimates and Projections (2016-2027)
3 Global Neurological Biomarkers Competition Landscape by Players
3.1 Global Top Neurological Biomarkers Players by Sales (2016-2021)
3.2 Global Top Neurological Biomarkers Players by Revenue (2016-2021)
3.3 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2020)
3.4 Global Neurological Biomarkers Average Price by Company (2016-2021)
3.5 Manufacturers Neurological Biomarkers Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Neurological Biomarkers Market Size by Type
4.1 Global Neurological Biomarkers Historic Market Review by Type (2016-2021)
4.1.1 Global Neurological Biomarkers Sales Market Share by Type (2016-2021)
4.1.2 Global Neurological Biomarkers Revenue Market Share by Type (2016-2021)
4.1.3 Global Neurological Biomarkers Price by Type (2016-2021)
4.2 Global Neurological Biomarkers Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Neurological Biomarkers Sales Forecast by Type (2022-2027)
4.2.2 Global Neurological Biomarkers Revenue Forecast by Type (2022-2027)
4.2.3 Global Neurological Biomarkers Price Forecast by Type (2022-2027)
5 Global Neurological Biomarkers Market Size by Application
5.1 Global Neurological Biomarkers Historic Market Review by Application (2016-2021)
5.1.1 Global Neurological Biomarkers Sales Market Share by Application (2016-2021)
5.1.2 Global Neurological Biomarkers Revenue Market Share by Application (2016-2021)
5.1.3 Global Neurological Biomarkers Price by Application (2016-2021)
5.2 Global Neurological Biomarkers Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Neurological Biomarkers Sales Forecast by Application (2022-2027)
5.2.2 Global Neurological Biomarkers Revenue Forecast by Application (2022-2027)
5.2.3 Global Neurological Biomarkers Price Forecast by Application (2022-2027)
6 North America Neurological Biomarkers Market Facts & Figures
6.1 North America Neurological Biomarkers Sales by Company
6.1.1 North America Neurological Biomarkers Sales by Company (2016-2021)
6.1.2 North America Neurological Biomarkers Revenue by Company (2016-2021)
6.2 North America Neurological Biomarkers Sales Breakdown by Type
6.2.1 North America Neurological Biomarkers Sales Breakdown by Type (2016-2021)
6.2.2 North America Neurological Biomarkers Sales Breakdown by Type (2022-2027)
6.3 North America Neurological Biomarkers Sales Breakdown by Application
6.3.1 North America Neurological Biomarkers Sales Breakdown by Application (2016-2021)
6.3.2 North America Neurological Biomarkers Sales Breakdown by Application (2022-2027)
7 Europe Neurological Biomarkers Market Facts & Figures
7.1 Europe Neurological Biomarkers Sales by Company
7.1.1 Europe Neurological Biomarkers Sales by Company (2016-2021)
7.1.2 Europe Neurological Biomarkers Revenue by Company (2016-2021)
7.2 Europe Neurological Biomarkers Sales Breakdown by Type
7.2.1 Europe Neurological Biomarkers Sales Breakdown by Type (2016-2021)
7.2.2 Europe Neurological Biomarkers Sales Breakdown by Type (2022-2027)
7.3 Europe Neurological Biomarkers Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)
8 China Neurological Biomarkers Market Facts & Figures
8.1 China Neurological Biomarkers Sales by Company
8.1.1 China Neurological Biomarkers Sales by Company (2016-2021)
8.1.2 China Neurological Biomarkers Revenue by Company (2016-2021)
8.2 China Neurological Biomarkers Sales Breakdown by Type
8.2.1 China Neurological Biomarkers Sales Breakdown by Type (2016-2021)
8.2.2 China Neurological Biomarkers Sales Breakdown by Type (2022-2027)
8.3 China Neurological Biomarkers Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Neurological Biomarkers Market Facts & Figures
9.1 Japan Neurological Biomarkers Sales by Company
9.1.1 Japan Neurological Biomarkers Sales by Company (2016-2021)
9.1.2 Japan Neurological Biomarkers Revenue by Company (2016-2021)
9.2 Japan Neurological Biomarkers Sales Breakdown by Type
9.2.1 Japan Neurological Biomarkers Sales Breakdown by Type (2016-2021)
9.2.2 Japan Neurological Biomarkers Sales Breakdown by Type (2022-2027)
9.3 Japan Neurological Biomarkers Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Neurological Biomarkers Market Facts & Figures
10.1 Southeast Asia Neurological Biomarkers Sales by Company
10.1.1 Southeast Asia Neurological Biomarkers Sales by Company (2016-2021)
10.1.2 Southeast Asia Neurological Biomarkers Revenue by Company (2016-2021)
10.2 Southeast Asia Neurological Biomarkers Sales Breakdown by Type
10.2.1 Southeast Asia Neurological Biomarkers Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Neurological Biomarkers Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Neurological Biomarkers Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Neurological Biomarkers Market Facts & Figures
11.1 India Neurological Biomarkers Sales by Company
11.1.1 India Neurological Biomarkers Sales by Company (2016-2021)
11.1.2 India Neurological Biomarkers Revenue by Company (2016-2021)
11.2 India Neurological Biomarkers Sales Breakdown by Type
11.2.1 India Neurological Biomarkers Sales Breakdown by Type (2016-2021)
11.2.2 India Neurological Biomarkers Sales Breakdown by Type (2022-2027)
11.3 India Neurological Biomarkers Sales Breakdown by Application
11.3.1 India Neurological Biomarkers Sales Breakdown by Application (2016-2021)
11.3.2 India Neurological Biomarkers Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Neurological Biomarkers Business
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Corporation Information
12.1.2 Thermo Fisher Scientific Business Overview
12.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Thermo Fisher Scientific Neurological Biomarkers Products Offered
12.1.5 Thermo Fisher Scientific Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Neurological Biomarkers Products Offered
12.2.5 Merck Recent Development
12.3 Quest Diagnostics
12.3.1 Quest Diagnostics Corporation Information
12.3.2 Quest Diagnostics Business Overview
12.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Quest Diagnostics Neurological Biomarkers Products Offered
12.3.5 Quest Diagnostics Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Business Overview
12.4.3 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbott Neurological Biomarkers Products Offered
12.4.5 Abbott Recent Development
12.5 Roche
12.5.1 Roche Corporation Information
12.5.2 Roche Business Overview
12.5.3 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Roche Neurological Biomarkers Products Offered
12.5.5 Roche Recent Development
12.6 Illumina
12.6.1 Illumina Corporation Information
12.6.2 Illumina Business Overview
12.6.3 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Illumina Neurological Biomarkers Products Offered
12.6.5 Illumina Recent Development
12.7 Bio-Rad Laboratories
12.7.1 Bio-Rad Laboratories Corporation Information
12.7.2 Bio-Rad Laboratories Business Overview
12.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bio-Rad Laboratories Neurological Biomarkers Products Offered
12.7.5 Bio-Rad Laboratories Recent Development
12.8 QIAGEN
12.8.1 QIAGEN Corporation Information
12.8.2 QIAGEN Business Overview
12.8.3 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.8.4 QIAGEN Neurological Biomarkers Products Offered
12.8.5 QIAGEN Recent Development
12.9 Myriad RBM
12.9.1 Myriad RBM Corporation Information
12.9.2 Myriad RBM Business Overview
12.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Myriad RBM Neurological Biomarkers Products Offered
12.9.5 Myriad RBM Recent Development
12.10 Cisbio Bioassays
12.10.1 Cisbio Bioassays Corporation Information
12.10.2 Cisbio Bioassays Business Overview
12.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Cisbio Bioassays Neurological Biomarkers Products Offered
12.10.5 Cisbio Bioassays Recent Development
12.11 Athena Diagnostics
12.11.1 Athena Diagnostics Corporation Information
12.11.2 Athena Diagnostics Business Overview
12.11.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Athena Diagnostics Neurological Biomarkers Products Offered
12.11.5 Athena Diagnostics Recent Development
12.12 BGI
12.12.1 BGI Corporation Information
12.12.2 BGI Business Overview
12.12.3 BGI Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.12.4 BGI Neurological Biomarkers Products Offered
12.12.5 BGI Recent Development
12.13 Wuxi APP
12.13.1 Wuxi APP Corporation Information
12.13.2 Wuxi APP Business Overview
12.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Wuxi APP Neurological Biomarkers Products Offered
12.13.5 Wuxi APP Recent Development
12.14 Aepodia
12.14.1 Aepodia Corporation Information
12.14.2 Aepodia Business Overview
12.14.3 Aepodia Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Aepodia Neurological Biomarkers Products Offered
12.14.5 Aepodia Recent Development
12.15 Proteome Sciences
12.15.1 Proteome Sciences Corporation Information
12.15.2 Proteome Sciences Business Overview
12.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Proteome Sciences Neurological Biomarkers Products Offered
12.15.5 Proteome Sciences Recent Development
12.16 Genewiz
12.16.1 Genewiz Corporation Information
12.16.2 Genewiz Business Overview
12.16.3 Genewiz Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Genewiz Neurological Biomarkers Products Offered
12.16.5 Genewiz Recent Development
13 Neurological Biomarkers Manufacturing Cost Analysis
13.1 Neurological Biomarkers Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Neurological Biomarkers
13.4 Neurological Biomarkers Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Neurological Biomarkers Distributors List
14.3 Neurological Biomarkers Customers
15 Market Dynamics
15.1 Neurological Biomarkers Market Trends
15.2 Neurological Biomarkers Drivers
15.3 Neurological Biomarkers Market Challenges
15.4 Neurological Biomarkers Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Neurological Biomarkers Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Neurological Biomarkers Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Neurological Biomarkers Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Neurological Biomarkers Sales (K Units) by Region (2016-2021)
Table 5. Global Neurological Biomarkers Sales Market Share by Region (2016-2021)
Table 6. Global Neurological Biomarkers Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Neurological Biomarkers Revenue Share by Region (2016-2021)
Table 8. Global Neurological Biomarkers Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Neurological Biomarkers Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Neurological Biomarkers Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Neurological Biomarkers Revenue Share Forecast by Region (2022-2027)
Table 12. Global Neurological Biomarkers Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Neurological Biomarkers Sales Share by Company (2016-2021)
Table 14. Global Neurological Biomarkers Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Neurological Biomarkers Revenue Share by Company (2016-2021)
Table 16. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurological Biomarkers as of 2020)
Table 17. Global Neurological Biomarkers Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Neurological Biomarkers Manufacturing Sites and Area Served
Table 19. Manufacturers Neurological Biomarkers Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Neurological Biomarkers Sales (K Units) by Type (2016-2021)
Table 22. Global Neurological Biomarkers Sales Share by Type (2016-2021)
Table 23. Global Neurological Biomarkers Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Neurological Biomarkers Price (USD/Unit) by Type (2016-2021)
Table 25. Global Neurological Biomarkers Sales Share by Type (2022-2027)
Table 26. Global Neurological Biomarkers Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Neurological Biomarkers Revenue Share by Type (2022-2027)
Table 28. Global Neurological Biomarkers Price (USD/Unit) by Type (2022-2027)
Table 29. Global Neurological Biomarkers Sales (K Units) by Application (2016-2021)
Table 30. Global Neurological Biomarkers Sales Share by Application (2016-2021)
Table 31. Global Neurological Biomarkers Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Neurological Biomarkers Price (USD/Unit) by Application (2016-2021)
Table 33. Global Neurological Biomarkers Sales (K Units) by Application (2022-2027)
Table 34. Global Neurological Biomarkers Sales Share by Application (2022-2027)
Table 35. Global Neurological Biomarkers Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Neurological Biomarkers Revenue Share by Application (2022-2027)
Table 37. Global Neurological Biomarkers Price (USD/Unit) by Application (2022-2027)
Table 38. North America Neurological Biomarkers Sales (K Units) by Company (2016-2021)
Table 39. North America Neurological Biomarkers Sales Market Share by Company (2016-2021)
Table 40. North America Neurological Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Neurological Biomarkers Revenue Market Share by Company (2016-2021)
Table 42. North America Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 43. North America Neurological Biomarkers Sales Market Share by Type (2016-2021)
Table 44. North America Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 45. North America Neurological Biomarkers Sales Market Share by Type (2022-2027)
Table 46. North America Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 47. North America Neurological Biomarkers Sales Market Share by Application (2016-2021)
Table 48. North America Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 49. North America Neurological Biomarkers Sales Market Share by Application (2022-2027)
Table 50. Europe Neurological Biomarkers Sales (K Units) by Company (2016-2021)
Table 51. Europe Neurological Biomarkers Sales Market Share by Company (2016-2021)
Table 52. Europe Neurological Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Neurological Biomarkers Revenue Market Share by Company (2016-2021)
Table 54. Europe Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 55. Europe Neurological Biomarkers Sales Market Share by Type (2016-2021)
Table 56. Europe Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 57. Europe Neurological Biomarkers Sales Market Share by Type (2022-2027)
Table 58. Europe Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 59. Europe Neurological Biomarkers Sales Market Share by Application (2016-2021)
Table 60. Europe Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 61. Europe Neurological Biomarkers Sales Market Share by Application (2022-2027)
Table 62. China Neurological Biomarkers Sales (K Units) by Company (2016-2021)
Table 63. China Neurological Biomarkers Sales Market Share by Company (2016-2021)
Table 64. China Neurological Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Neurological Biomarkers Revenue Market Share by Company (2016-2021)
Table 66. China Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 67. China Neurological Biomarkers Sales Market Share by Type (2016-2021)
Table 68. China Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 69. China Neurological Biomarkers Sales Market Share by Type (2022-2027)
Table 70. China Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 71. China Neurological Biomarkers Sales Market Share by Application (2016-2021)
Table 72. China Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 73. China Neurological Biomarkers Sales Market Share by Application (2022-2027)
Table 74. Japan Neurological Biomarkers Sales (K Units) by Company (2016-2021)
Table 75. Japan Neurological Biomarkers Sales Market Share by Company (2016-2021)
Table 76. Japan Neurological Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Neurological Biomarkers Revenue Market Share by Company (2016-2021)
Table 78. Japan Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 79. Japan Neurological Biomarkers Sales Market Share by Type (2016-2021)
Table 80. Japan Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 81. Japan Neurological Biomarkers Sales Market Share by Type (2022-2027)
Table 82. Japan Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 83. Japan Neurological Biomarkers Sales Market Share by Application (2016-2021)
Table 84. Japan Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 85. Japan Neurological Biomarkers Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Neurological Biomarkers Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Neurological Biomarkers Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Neurological Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Neurological Biomarkers Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Neurological Biomarkers Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Neurological Biomarkers Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Neurological Biomarkers Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Neurological Biomarkers Sales Market Share by Application (2022-2027)
Table 98. India Neurological Biomarkers Sales (K Units) by Company (2016-2021)
Table 99. India Neurological Biomarkers Sales Market Share by Company (2016-2021)
Table 100. India Neurological Biomarkers Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Neurological Biomarkers Revenue Market Share by Company (2016-2021)
Table 102. India Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 103. India Neurological Biomarkers Sales Market Share by Type (2016-2021)
Table 104. India Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 105. India Neurological Biomarkers Sales Market Share by Type (2022-2027)
Table 106. India Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 107. India Neurological Biomarkers Sales Market Share by Application (2016-2021)
Table 108. India Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 109. India Neurological Biomarkers Sales Market Share by Application (2022-2027)
Table 110. Thermo Fisher Scientific Corporation Information
Table 111. Thermo Fisher Scientific Description and Business Overview
Table 112. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Thermo Fisher Scientific Neurological Biomarkers Product
Table 114. Thermo Fisher Scientific Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Merck Neurological Biomarkers Product
Table 119. Merck Recent Development
Table 120. Quest Diagnostics Corporation Information
Table 121. Quest Diagnostics Description and Business Overview
Table 122. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Quest Diagnostics Neurological Biomarkers Product
Table 124. Quest Diagnostics Recent Development
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Abbott Neurological Biomarkers Product
Table 129. Abbott Recent Development
Table 130. Roche Corporation Information
Table 131. Roche Description and Business Overview
Table 132. Roche Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Roche Neurological Biomarkers Product
Table 134. Roche Recent Development
Table 135. Illumina Corporation Information
Table 136. Illumina Description and Business Overview
Table 137. Illumina Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Illumina Neurological Biomarkers Product
Table 139. Illumina Recent Development
Table 140. Bio-Rad Laboratories Corporation Information
Table 141. Bio-Rad Laboratories Description and Business Overview
Table 142. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Bio-Rad Laboratories Neurological Biomarkers Product
Table 144. Bio-Rad Laboratories Recent Development
Table 145. QIAGEN Corporation Information
Table 146. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. QIAGEN Description and Business Overview
Table 148. QIAGEN Neurological Biomarkers Product
Table 149. QIAGEN Recent Development
Table 150. Myriad RBM Corporation Information
Table 151. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Myriad RBM Description and Business Overview
Table 153. Myriad RBM Neurological Biomarkers Product
Table 154. Myriad RBM Recent Development
Table 155. Cisbio Bioassays Corporation Information
Table 156. Cisbio Bioassays Description and Business Overview
Table 157. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Cisbio Bioassays Neurological Biomarkers Product
Table 159. Cisbio Bioassays Recent Development
Table 160. Athena Diagnostics Corporation Information
Table 161. Athena Diagnostics Description and Business Overview
Table 162. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Athena Diagnostics Neurological Biomarkers Product
Table 164. Athena Diagnostics Recent Development
Table 165. BGI Corporation Information
Table 166. BGI Description and Business Overview
Table 167. BGI Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. BGI Neurological Biomarkers Product
Table 169. BGI Recent Development
Table 170. Wuxi APP Corporation Information
Table 171. Wuxi APP Description and Business Overview
Table 172. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Wuxi APP Neurological Biomarkers Product
Table 174. Wuxi APP Recent Development
Table 175. Aepodia Corporation Information
Table 176. Aepodia Description and Business Overview
Table 177. Aepodia Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Aepodia Neurological Biomarkers Product
Table 179. Aepodia Recent Development
Table 180. Proteome Sciences Corporation Information
Table 181. Proteome Sciences Description and Business Overview
Table 182. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 183. Proteome Sciences Neurological Biomarkers Product
Table 184. Proteome Sciences Recent Development
Table 185. Genewiz Corporation Information
Table 186. Genewiz Description and Business Overview
Table 187. Genewiz Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 188. Genewiz Neurological Biomarkers Product
Table 189. Genewiz Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Neurological Biomarkers Distributors List
Table 193. Neurological Biomarkers Customers List
Table 194. Neurological Biomarkers Market Trends
Table 195. Neurological Biomarkers Market Drivers
Table 196. Neurological Biomarkers Market Challenges
Table 197. Neurological Biomarkers Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurological Biomarkers Product Picture
Figure 2. Global Neurological Biomarkers Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Neurological Biomarkers Sales Market Share by Application in 2021 & 2027
Figure 6. Diagnostics Examples
Figure 7. Drug Discovery Examples
Figure 8. Personalized Medicine Examples
Figure 9. Others Examples
Figure 10. Global Neurological Biomarkers Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Neurological Biomarkers Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Neurological Biomarkers Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Neurological Biomarkers Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Neurological Biomarkers Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Neurological Biomarkers Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Neurological Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Neurological Biomarkers Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Neurological Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Neurological Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Neurological Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Neurological Biomarkers Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Neurological Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Neurological Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Neurological Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Neurological Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Neurological Biomarkers Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Neurological Biomarkers Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Neurological Biomarkers Players Market Share by Revenue in Neurological Biomarkers: 2016 & 2020
Figure 29. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Neurological Biomarkers Revenue Share by Type (2016-2021)
Figure 31. Global Neurological Biomarkers Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Neurological Biomarkers Revenue Share by Application (2016-2021)
Figure 33. Global Neurological Biomarkers Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Neurological Biomarkers Sales Market Share by Type in 2020
Figure 35. North America Neurological Biomarkers Sales Market Share by Application in 2020
Figure 36. Europe Neurological Biomarkers Sales Market Share by Type in 2020
Figure 37. Europe Neurological Biomarkers Sales Market Share by Application in 2020
Figure 38. China Neurological Biomarkers Sales Market Share by Type in 2020
Figure 39. China Neurological Biomarkers Sales Market Share by Application in 2020
Figure 40. Japan Neurological Biomarkers Sales Market Share by Type in 2020
Figure 41. Japan Neurological Biomarkers Sales Market Share by Application in 2020
Figure 42. Southeast Asia Neurological Biomarkers Sales Market Share by Type in 2020
Figure 43. Southeast Asia Neurological Biomarkers Sales Market Share by Application in 2020
Figure 44. India Neurological Biomarkers Sales Market Share by Type in 2020
Figure 45. India Neurological Biomarkers Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Neurological Biomarkers
Figure 48. Manufacturing Process Analysis of Neurological Biomarkers
Figure 49. Neurological Biomarkers Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界の診断バイオマーカー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diagnostic Biomarkers Market The global Diagnostic Biomarkers market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…- 世界の神経疾患診断市場規模・現状・予測（2021年-2027年） Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders. Market Analysis and Insights: Global Neurological Disorder Diagnostics Market The global Neurological Disorder Diagnostics market size is projected to reach US$ 13800 million by 2027, from US$ 10080 mi…
- 世界の臨床バイオマーカー市場規模・現状・予測（2021年-2027年） Biomarkers are a class of markers related to cell growth and proliferation that have been proposed in recent years with the development of immunology and molecular biology techniques. Biomarkers can not only discuss the pathogenesis at the molecular level, but also have a unique advantage in accurat…
- 世界の心臓バイオマーカー検査市場規模・現状・予測（2021年-2027年） Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and car…
- 神経疾患診断のグローバル市場：規模・現状・予測2019-2025 Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.In 2018, the global Neurological Disorder Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focus…